Table 1 |
||||
|
Biomarkers of bone, cartilage and synovial turnover, and the BIPED classification |
||||
|
Tissue |
Molecule |
Markers of synthesis |
Markers of degradation |
BIPED classification |
|
|
||||
|
Bone |
Type I collagen |
PYDa |
B |
|
|
NTX-Ia,b |
D |
|||
|
CTX-Ia,b |
P |
|||
|
Noncollagenous proteins |
Osteocalcinb |
P |
||
|
Cartilage |
Type II collagen |
PIIANPb |
P |
|
|
Total PIINP |
D |
|||
|
PIICPb,c |
D, P |
|||
|
CTX-IIa,c |
D, B, P, E |
|||
|
HELIX-IIa |
P |
|||
|
Coll 2-1a,b |
P |
|||
|
Coll 2-1 NO2a,b |
P |
|||
|
C2Ca,b |
P, E |
|||
|
1,2Ca,b |
P, E |
|||
|
Aggrecan |
Epitope 846 (cartilage contentc) |
E |
||
|
Nonaggrecan and noncollagenous proteins |
COMPb,c |
D, B, P |
||
|
Pentosidinea,b |
P |
|||
|
Proteases and their inhibitors |
MMPsb |
B, P, E |
||
|
TIMPsb |
B, P |
|||
|
Synovium |
Type III collagen |
GIc-GaI-PYDa |
E |
|
|
Noncolagenous proteins |
YKL-40b,c |
B, E |
||
|
Hayluronic acidb |
B, P |
|||
|
|
||||
|
aUrine. bSerum. c Synovial fluid. BIPED, B (burden of disease), I (investigative), P (prognostic), E (efficacy of intervention), D (diagnostic); C1,2C, assay that detects COL2-3/4C (short) epitope; C2C, assay that detects COL2-3/4C (long) epitope; Coll 2-1, 9-amino-acid peptide of type II collagen; Coll 2-1 NO2, nitrated form of Coll 2-1; COMP, cartilage oligomeric protein; CTX-I, carboxyl-terminal cross-linked telopeptide of type I collagen; CTX-II, C-terminal cross-linked telopeptide of type II collagen; Glc-Gal-PYD, glucosyl-galactosyl-pyridinoline; HELIX-II, helical type II collagen; MMP, matrix metalloproteinase; NTX-I, N-terminal cross-linked telopeptide of type I collagen; PIIANP, N-propeptide IIA of collagen type II; PIICP, C-propeptide of collagen type II; PIINP, N-propeptide II of collagen type II; PYD, pyridinoline; TIMP, tissue inhibitor of matrix metalloproteinase; YKL-40, cartilage glycoprotein 39. Reproduced with permission from Rouseeau and Delmas [80]. |
||||
|
Abramson and Attur Arthritis Research & Therapy 2009 11:227 doi:10.1186/ar2655 |
||||